| Events
Column |
|
| 4/11 8:00
am - 6:30 pm. Healthcare 2008 at the Yale School of
Management. "Whose Healthcare is it Anyway?
Understanding the Patient as a Consumer." Omni Hotel,
New Haven, CT. more |
|
| 4/16 3:30
pm - 6:00 pm. CURE and Yale OCR Present: The Next Big
Idea - Creating a New Venture. A Special BioHaven
Entrepreneurship Panel with Roger Longman of Windhover
Publications. Reception and networking to follow. Anlyan
Center, Congress Avenue, New Haven, CT. more |
|
| 4/19 8:00
am. Final round presentations begin re Y50K annual business
plan competition. more |
|
| 4/23 3:00
pm - 6:00 pm. CURE and Yale OCR Present: Vidus Ocular. A BioHaven
Entrepreneurship Seminar. Anlyan Center, Congress Avenue,
New Haven, CT. Reception and networking to follow. more |
|
| 4/29-30 Connecticut
Venture Group. Crossroads Venture Fair. Marriott Hotel,
Stamford. more |
|
|
|
Events
Strengthen Connecticut BioScience
From
the desk of Paul Pescatello, President and CEO of CURE
One
measure of the strength of Connecticut’s bioscience sector
is its calendar of events. Every year brings numerous
opportunities for CURE members and others to get together
for face-to-face networking and the exchange of ideas in
both formal and informal settings, and 2008 is no exception.
For
the full story |
|
Optherion
Focuses on Immune System Pathway to Treat Age-Related
Macular Degeneration
CURE/Yale
BioHaven Entrepreneuship Series Continues
Optherion,
Inc. is an early-stage biotechnology company focusing
on Age-Related Macular Degeneration and
other disorders of the immune system component known as the
alternative complement pathway. Presenting
the company's story March 19 in New Haven were Colin
Foster, president and CEO, and Amanda Hayward, Ph.D.,
senior vice president of Scheer & Company, the
Branford-based venture capital firm that led the early
organization and capitalization of the company. Frank Marco,
partner, of series sponsor Wiggin and Dana, introduced the
speakers.
For
the full story |
|
CURE
Member News Digest
 454
Life Sciences sequencers characterize
mesothelioma
Achillion
CEO cites 2007 progress
Alexion
sees progress in PNH diagnosis
Bayer
HealthCare unveils radiology management system
Boehringer
Ingelheim cited for COPD excellence
Bristol-Myers
Squibb announces new drug approval for ABILIFY®
Cantor
Colburn named Go-To Law Firm®
Danbury
Hospital repeats Children's Day
Genomas
gets fast-track SBIR grant
GlaxoSmithKline
presents data on asthma
Johnson
& Johnson gets marketing clearance for
stent system
MannKind
proud of 2007 accomplishments
NanoViricides
candidates seen as effective against Ebola
Neurogen expands
role for adipiplon
Pfizer
to acquire livestock genomics companies
PhRMA
data shows drug cost rise modest
Vion
reports progress on Cloretazine® filing
WinStanley
Enterprises to build garage at 25 Science Park
UConn
reports osteoarthritis stem cell work
Yale
develops blood test for ovarian cancer
For
the full story |
|
